FDAnews
www.fdanews.com/articles/96279-vivalis-ebx-proof-of-concept-for-production-of-antibodies

Vivalis EBx Proof of Concept for Production of Antibodies

July 24, 2007

Vivalis announced first promising data resulting from a scientific collaboration with Mat Biopharma to evaluate Vivalis EBx cell lines for the production of Mat Biopharma’s monoclonal antibodies. The results confirm the strong potential of the EBx cell lines for the monoclonal antibody market.
Yahoo Finance